Patents by Inventor Jose Russo

Jose Russo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240000895
    Abstract: Methods of treating nulligravid females having a high risk of developing breast cancer and without exposure to a contraceptive by administering human chorionic gonadotropin (hCG), methods of monitoring the treatment efficacy of a subject having breast cancer or having a high risk of developing breast cancer, and methods of determining whether a subject is at risk of developing breast cancer are provided herein.
    Type: Application
    Filed: December 6, 2021
    Publication date: January 4, 2024
    Inventors: Jose Russo, Herman Depypere, Yanrong Su, Nhi Dang, Jaak Janssens
  • Patent number: 11697674
    Abstract: The present disclosure provides hCG variant proteins, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of treating cancer.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: July 11, 2023
    Assignee: Institute For Cancer Research
    Inventors: Jose Russo, Yanrong Su, Julia Santucci Pereira Del Buono, Mark Andrake
  • Publication number: 20220041679
    Abstract: The present disclosure provides hCG variant proteins, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of treating cancer.
    Type: Application
    Filed: October 15, 2018
    Publication date: February 10, 2022
    Applicant: Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
    Inventors: Jose Russo, Yanrong Su, Julia Santucci Pereira Del Buono, Mark Andrake
  • Publication number: 20210188935
    Abstract: The present disclosure provides hCG variant proteins, nucleic acid molecules encoding the same, vectors comprising nucleic acid molecules, compositions comprising the same, and methods of treating cancer.
    Type: Application
    Filed: October 15, 2018
    Publication date: June 24, 2021
    Applicant: Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center
    Inventors: Jose Russo, Yanrong Su, Julia Santucci Pereira Del Buono, Mark Andrake
  • Patent number: 8969304
    Abstract: This relates to the prevention of cancer initiation. More specifically, the invention provides compositions and methods useful for altering the genetic signature in breast tissue, said alteration being correlated with a reduced risk for the development of breast cancer.
    Type: Grant
    Filed: April 8, 2011
    Date of Patent: March 3, 2015
    Assignee: The Institute for Cancer Research
    Inventors: Jose Russo, Irma H. Russo
  • Publication number: 20130064882
    Abstract: This relates to the prevention of cancer initiation. More specifically, the invention provides compositions and methods useful for altering the genetic signature in breast tissue, said alteration being correlated with a reduced risk for the development of breast cancer.
    Type: Application
    Filed: April 8, 2011
    Publication date: March 14, 2013
    Applicant: FOX CHASE CANCER CENTER
    Inventors: Jose Russo, Irma H. Russo
  • Publication number: 20100285995
    Abstract: Compositions and methods for the diagnosis and treatment of breast cancer are provided.
    Type: Application
    Filed: January 2, 2009
    Publication date: November 11, 2010
    Inventors: Jose Russo, Irma Russo
  • Patent number: 7183251
    Abstract: This invention relates to the field of cancer therapy. More particularly, the invention relates to the treatment of mammary tumor, clinically manifest mammary tumor (breast cancer) and metastatic mammary tumor by administration of human Chorionic Gonadotropin (hCG). The treatment preferably comprises the administration of hCG in conjunction with an antiestrogen and/or a Type I Interferon.
    Type: Grant
    Filed: December 15, 1999
    Date of Patent: February 27, 2007
    Assignees: Fox Chase Cancer Center, Applied Research Systems ARS Holdings N.V.
    Inventors: Irma H. Russo, Jose Russo, Giampiero Deluca, Jaak Janssens